Table 4. HSCT Outcome.
| Outcome parameters | N | (%) | |
|---|---|---|---|
| Engraftment | |||
| Yes | 45 | 90 | |
| No | 5 | 10 | |
| Not evaluable | 3 | ||
| Day of engraftment (days) | 15 (11–23) | ||
| Rejection | |||
| Yes | 4 | 8.8889 | |
| No | 41 | 91.111 | |
| Not evaluable | 8 | ||
| Chimerism | |||
| Complete | 36 | 81.818 | |
| Mixed | 8 | 18.182 | |
| Not evaluable | 9 | ||
| Mucositis | |||
| Yes | 37 | 74 | Grade 0–1: 17 |
| No | 13 | 26 | Grade 2–4: 33 |
| Not evaluable | 3 | ||
| aGvHD | |||
| Yes | 15 | 32.609 | Grade 0–1:31 |
| No | 31 | 67.391 | Grade 2–4:15 |
| Not evaluable | 7 | ||
| cGvHD | |||
| Yes | 16 | 41.026 | Grade 0–1:23 |
| No | 23 | 58.974 | Grade 2–4:16 |
| Not evaluable | 14 | ||
| TRMa | |||
| Yes | 16 | 30.189 | |
| No | 37 | 69.811 | |
Abbreviations: aGvHD=acute GvHD; cGvHD=chronic GvHD; HSCT=hematopoietic stem cell transplantation; TRM=transplant-related mortality.
The primary reasons for deaths were infection, GvHD and multi organ failure.